Clinical relevance of circulating cell-free microRNAs in cancer

By H. Schwarzenbach, N. Nishida, George A. Calin, K. Pantel. Nature Reviews Clinical Oncology, 2014

1,025 citations recorded by the source corpus.

Subfields: Cancer Research, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/2e087c3dcda94b642f9c8908c4d628cac9299df1

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

1. Zhou Huang
2. Yuan Zhou
3. Qinghua Cui

In Molecular Biology

1. Zhou Huang
2. Yuan Zhou
3. Qinghua Cui

Citations in the corpus

• HMDD v3.0: a database for experimentally supported human microRNA–disease associations (2018, background): “For example, miRNAs can both promote and suppress cancers occurrence and progression, and they can serve as diagnosis and prognosis biomarkers (8–11) and novel therapeutic targets for the treatment of cancers (12,13).”